Growth Metrics

Fulgent Genetics (FLGT) Total Non-Current Liabilities (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Total Non-Current Liabilities for 10 consecutive years, with $99.5 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 15.4% to $99.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $99.5 million through Dec 2025, up 15.4% year-over-year, with the annual reading at $99.5 million for FY2025, 15.4% up from the prior year.
  • Total Non-Current Liabilities hit $99.5 million in Q4 2025 for Fulgent Genetics, up from $91.8 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $197.0 million in Q1 2021 to a low of $74.7 million in Q2 2023.
  • Historically, Total Non-Current Liabilities has averaged $108.8 million across 5 years, with a median of $98.2 million in 2023.
  • Biggest five-year swings in Total Non-Current Liabilities: surged 156.21% in 2021 and later tumbled 49.96% in 2023.
  • Year by year, Total Non-Current Liabilities stood at $106.0 million in 2021, then grew by 0.29% to $106.3 million in 2022, then fell by 18.23% to $87.0 million in 2023, then fell by 0.82% to $86.2 million in 2024, then rose by 15.4% to $99.5 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for FLGT at $99.5 million in Q4 2025, $91.8 million in Q3 2025, and $88.0 million in Q2 2025.